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 Most if not all cell types of diverse organ-
isms release membranous nano-sized vesi-
cles that harbor RNA, proteins, and lipids. 
Th ese microparticles (MPs) include micro-
vesicles (100  nm to 1   m) generated by sur-
face shedding of plasma membrane 
containing cytoplasm; and exosomes (40 –
 100  nm) originating from the membrane of 
endosomal multivesicular bodies (MVBs) 
and released into the extracellular environ-
ment during exocytosis upon fusion with 
the plasma membrane. The function of 
these extracellular vesicles is just beginning 
to become apparent. Th ey play a role in 
cell – cell communication and may have 
pathological functions in immune proc-
esses and cancer progression ( Figure 1 ). 
 In kidney research, urinary MPs are 
being actively investigated as biomarkers 
and mediators of extracellular communi-
cation between renal epithelial cells. 1 Cur-
rently, only a few studies have examined 
the impact of MPs derived from extrarenal 
cells on kidney injury. MPs originating 
from mesenchymal stem and endothelial 
progenitor cells were found to convey 
signals that ameliorate tubular injury. For 
endothelial cell-derived MPs, horizontal 
transfer of mRNA and activation of an 
angiogenic program in the recipient 
endothelial cells has been suggested as the 
underlying mechanism. 2 MicroRNAs 
(miRNAs), small regulatory RNA mole-
cules, are actively secreted packaged in 
MPs and / or bound to proteins from diff er-
ent cell types, including mast cells and 
embryonic stem cells. 3 Cantallupi  et al. 4 
(this issue) show that MPs from endothe-
lial progenitor cells (EPCs) isolated from 
peripheral blood mononuclear cells of 
healthy human donors protect against 
acute and long-term consequences of 
ischemia – reperfusion injury in rats, if 
injected in the tail vein immediately aft er 
ischemic injury. MPs derived from fi bro-
blasts or from EPCs treated with Dicer 
small interfering RNA or miR-126 and 
miR-296 inhibitors, or preincubated with 
RNase, failed to ameliorate ischemia – 
reperfusion injury. In addition, hypoxia-
induced uptake of MPs diminishes 
apoptosis and promotes proangiogenic and 
antiapoptotic gene expression in cultured 
primary tubular endothelial and epithelial 
cells, in a manner at least partially depend-
ent on miR-126 and miR-296. 
 Th ese fi ndings support previous work by 
the authors and other groups on the role of 
progenitor cells in kidney injury but also 
point out gaps in our understanding of 
MPs and their cargo: What is the diff erence 
between vesicles that ameliorate injury 
(MPs derived from EPCs) and those that 
have less or no effect (MPs from fibro-
blasts)? In this respect it needs to be 
emphasized that the term  ‘ EPC ’ is indeed 
controversial, as it may include multiple 
cell types with diff erent functions. EPCs 
circulate in the bloodstream and contribute 
mainly by paracrine actions to formation 
of new blood vessels, endothelial repair, 
and vascular homeostasis. 5 Impairment of 
EPCs is related to endothelial dysfunction 
and adverse clinical outcome. 6 EPCs are 
obtained by an adhesion-related isolation 
method and are defi ned by expression of 
the endothelial lineage markers, such as 
CD31, KDR (VEGFR-2), VE-cadherin, 
and von Willebrand factor. EPCs also show 
certain endothelial properties, such as 
migration toward proangiogenic factors. 
However, these early EPCs are also referred 
to as circulating angiogenic cells, mono-
cytic EPCs, early-outgrowth EPCs, or ang-
iogenic progenitor cells. 5 Th e cell type used 
by many groups and investigated by 
Camussi ’ s group (Camussi  et al. 2,3 and 
Cantaluppi  et al. 4 ) can also be described as 
circulating angiogenic cells. Future research 
will have to determine whether the fi nd-
ings of Camussi ’ s group with regard to the 
observed beneficial effects and miRNA 
content are generally comparable among 
diff erent  ‘ EPC ’ subtypes identifi ed so far. 
 Th e current paper by Cantaluppi  et al. 4 
attributes the protective eff ect to miR-126 
and miR-296, which are detected in the 
microvesicles by reverse transcription PCR. 
Mouse knockout of miR-126 was found to 
be the cause of a severe vascular phenotype 
initially ascribed to its host gene,  Egfl 7 . 7 
Like its host gene, miR-126 is primarily 
expressed in endothelium. In a large 
small-RNA sequencing database, miR-126 
composed up to 10 – 15 % of the total 
miRNA content in tissues with a dominant 
endothelial component (angio sarcoma, 
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micro dissected glomeruli, heart), with 
levels of about 3 – 5 % noted in CD34   +   lym-
phocytes, peripheral blood mono nuclear 
cells, and fetal lung (T. Tuschl, personal 
communication, Laboratory of RNA 
Molecular Biology, Howard Hughes Medi-
cal Institute, Rockefeller University, New 
York, NY). As EPCs frequently can take up 
platelets and thus also their molecular con-
tent, the real source of certain miRNAs 
detected in EPCs remains to be determined. 
MiR-126 and many of its targets are highly 
expressed in endothelial cells, and both 
miR-126 and miR-296 have been impli-
cated in angiogenesis 8 (although expression 
in the tissue database was not nearly as high 
for miR-296, and no enrichment was noted 
in samples containing endothelium). Th e 
notion that miRNAs are also transferred to 
other cell types urges us now to identify 
also cell type-specifi c targets of transferred 
miRNAs, especially if they are normally not 
expressed in this cell type, which is the case 
for tubular epithelial cells and miR-126 
(I.Z.B.-D., unpublished observations). 
Thus, the targets of miR-126 in diverse 
kidney cells remain to be determined. 
 MiRNAs might be enriched in MPs, 
and the machinery required for miRNA 
function has recently been linked to 
multivesicular bodies (MVBs). MiRNAs 
require the RNA-induced silencing 
complex (RISC) for downregulation of 
expression of target genes, but formation 
and turnover of the RISC itself are tightly 
regulated and require endosomal mem-
branes. MVBs associate with RISC 
and GW bodies, and the blocking of MVB 
formation results in impaired silencing 
of mRNA by miRNAs, indicating that 
active RISC is physically and functionally 
coupled to MVBs. 9 It remains to be deter-
mined whether this association results 
in enrichment of RISC-associated small 
RNAs in exosomes, which originate 
from MVBs, and in regulation of miRNA 
content in MPs in physiology and 
disease. 
 Notwithstanding the above discussion, 
it cannot be ruled out that the cargo RNA 
mediator of the protective eff ect of MPs 
is not the miRNA but an indirect mRNA 
target. For this to happen, the putative 
transcript would have to be upregulated 
by miR-126; that is, miR-126 would target 
a repressor of this mRNA. In fact, the 
latter mechanism may be favored on the 
basis of stoichiometric considerations. 
Assuming the total take-up of MPs by the 
cell amounts to 1:1000 of its volume 
(probably an overestimate), the delivered 
miRNA, even if enriched in the vesicle, is 
much diluted compared with its concen-
tration in the parent cell. Since miRNAs 
perform their function on a 1:1 basis with 
their targets (and must compete with 
 ‘ native ’ miRNA in RISC loading), signifi -
cant regulation of a target gene is implau-
sible in most cases. On the other hand, a 
newly introduced mRNA is more likely 
to cause a switch, as it can be used to gene-
rate many protein molecules, departing 
from the 1:1 relationship. Additionally, 
mRNAs are also more susceptible to ribo-
nuclease digestion, which is consistent 
with the fi ndings of Cantaluppi  et al. 4 
that RNase treatment abolishes the eff ect 
of MPs. 
 Th e fi ndings reported by Cantaluppi 
 et al. 4 suggest that MPs from unchallenged 
EPCs protect from ischemia – reperfusion 
injury. It can be speculated whether 
circulating MPs constitute an additional 
physiological mechanism to counter 
endothelial damage that may be altered in 
disease states. Furthermore, the authors 
show that dye-labeled MPs were detected 
not only in endothelial but also in tubular 
epithelial cells 2 hours aft er tail vein injec-
tion and that MPs have measurable eff ects 
in cultured tubular epithelial cells. As 
MPs appear to be too large to enter the 
tubular lumen through the glomerular 
filtration barrier to reach the tubular 
epithelial cells via the urinary space, 
MPs would need to migrate from the 
blood through the basal membrane to the 
tubular epithelium. 
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 Figure 1  |  MicroRNA biogenesis and transport. MicroRNAs (miRNAs) are transcribed from 
miRNA genes that are similar to protein-coding genes into primary miRNAs (pri-miRNAs; several 
hundreds of nucleotides long, harboring 5  cap and 3  poly-A tail), further processed into pre-
miRNAs ( ~ 70 nucleotides long with a characteristic hairpin loop) by the RNase III enzyme Drosha in 
the nucleus, and shuttled into the cytoplasm through Exportin 5, where the RNase III enzyme Dicer 
generates mature miRNAs and passenger strand. Mature miRNAs are then incorporated into the 
RNA-induced silencing complex (RISC), where target mRNAs are either degraded or translationally 
repressed through partial sequence complementation. In the extracellular space, miRNAs have been 
detected in microvesicles and exosomes, and bound to extracellular particles and proteins. The RISC 
has been found to be associated with the membranes of multivesicular bodies (MVBs) derived from 
the endosome and in microvesicles; it is probably also in exosomes. The mechanisms underlying 
uptake of miRNAs into vesicles and the release from the vesicles in target cells are largely unknown. 
commentar y
Kidney International (2012) 82     377
 Obstructive nephropathy is one of the 
common causes of acute renal failure and 
end-stage renal disease. Many animal 
 Current knowledge supports further 
exploration of the complex interplay 
between the microRNA machinery and 
endosomal vesicles, as well as the mecha-
nisms of cargo loading into microvesicles 
and exosomes, the recognition of target 
cells by MPs, and the alteration of gene 
and protein expression in target cells by 
cargo of MPs ( Figure 1 ). Better under-
standing of the biology of MPs and their 
content is important before genetically 
altered vesicles can be considered as 
potential novel therapeutic carriers. 
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models have been developed to study the 
renal consequences of ureteral obstruc-
tion in the events of acute, chronic, or 
congenital ureteropelvic junction obstruc-
tion. 1 Most studies on renal parenchyma 
alterations have focused on glomerular 
changes, tubulointerstitial injury, and 
fi brosis. 2,3 Instead, Girshovich  et al. 4 (this 
issue) turn their attention to a small group 
of cells called the intrarenal urothelium 
that resides near the fornices (corticomed-
ullary junction). 
 Th e intrarenal urothelium is morpho-
logically and phenotypically distinct from 
the bladder urothelium. Th e renal urothe-
lium, near the fornices, is composed of 
one- or two-layered epithelium, whereas 
the bladder epithelium is a multilayered 
epithelium consisting of basal cells, inter-
mediate cells, and superfi cial umbrella 
cells. The apical surface of a bladder 
urothelium contains urothelial plaques 
that contribute to a tight permeability 
barrier, thus preventing rupture during 
bladder distension and the infl ux of urine 
from the bladder lumen. Th e urothelial 
plaques contain four major integral mem-
brane proteins, uroplakins Ia, Ib, II, and 
III. 5 Th e renal urothelium near the for-
nices, in contrast, showed much weaker 
uroplakin immunostaining compared 
with typical umbrella cells of the bladder 
urothelium. 6 Although the bladder 
urothelium is constantly subjected to pres-
sure changes, no signifi cant stretching 
occurs in the intrarenal urothelium under 
physiological conditions. In the event of 
hydronephrosis secondary to ureteral 
obstruction, the intrarenal urothelium 
becomes the first barrier subjected 
to pressure-induced stretching and 
deformation. 
 Using an adult mouse unilateral ureteral 
obstruction (UUO) model, Girshovich 
 et al. 4 designed a series of experiments to 
examine the morphological and pheno-
typical alterations of intrarenal urothe-
lium subjected to increased intrapelvic 
pressure. Th ey were able to demonstrate 
that the intrarenal urothelium diff erenti-
ated into a  ‘ bladder-like ’ urothelium fol-
lowing UUO. Th is bladder-like urothelium 
was characterized by a multilayered 
epithelium with strong expression of 
uroplakins Ib, II, and III. Th ese fi ndings 
were further substantiated by electron 
microscopy examination, in which the 
transformed renal urothelium within the 
obstructed kidney showed abundant 
uroplakin-containing vesicles and thick-
ened asymmetric unit membrane cover-
ing the entire apical surface, suggesting 
a much more efficient barrier to water 
and solutes compared with normal renal 
urothelium. 
 The authors also made several very 
interesting observations. Th ere was a sig-
nifi cant increase in the proliferation index 
